Muscle strength and fatigue in newly diagnosed patients with myasthenia gravis

Muscle and Nerve

Volumn 54, Issue 4, 2016, Pages 709-714

  Vinge, Lotte ^a   Andersen, Henning ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

dynamometry; fatigue; MG evaluation scales; muscle strength; myasthenia gravis; untreated patients

Indexed keywords

AZATHIOPRINE; CHOLINERGIC RECEPTOR ANTIBODY; MYCOPHENOLIC ACID; PREDNISOLONE; PYRIDOSTIGMINE;

ABDUCTION; ADULT; AGED; ANKLE; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYNAMOMETER; DYNAMOMETRY; FATIGUE; FEMALE; HUMAN; KNEE; MALE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; MYASTHENIA GRAVIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SHOULDER MUSCLE; VERY ELDERLY;

EID: 84986586574     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.25084     Document Type: Article

References (28)

1. Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet 2001;357:2122–2128.
2. Wolfe GI, Barohn RJ. Myasthenia gravis: classification and outcome measurements. In: Kaminski HJ, editor. Myasthenia gravis and related disorders. New York: Humana Press; 2009. p 293–302.
3. Burns TM. History of outcome measures for myasthenia gravis. Muscle Nerve 2010;42:5–13.
4. Burns TM. The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice. Ann N Y Acad Sci 2012;1274:99–106.
5. Burns TM, Conaway M, Sanders DB, MG Composite and MG-QOL15 Study Group. The MG composite: a valid and reliable outcome measure for myasthenia gravis. Neurology 2010;74:1434–1440.
6. Burns TM, Conaway MR, Cutter GR, Sanders DB, Muscle Study Group. Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite. Muscle Nerve 2008;38:1553–1562.
7. Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan WW. Reliability testing of the quantitative myasthenia gravis score. Ann N Y Acad Sci 1998;841:769–772.
8. Bedlack RS, Simel DL, Bosworth H, Samsa G, Tucker-Lipscomb B, Sanders DB. Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity. Neurology 2005;64:1968–1970.
9. Sanders DB, Tucker-Lipscomb B, Massey JM. A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score. Ann N Y Acad Sci 2003;998:440–444.
10. Burns TM, Conaway MR, Cutter GR, Sanders DB, Muscle Study Group. Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis. Muscle Nerve 2008;38:957–963.
11. Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ. Myasthenia gravis activities of daily living profile. Neurology 1999;52:1487–1489.
12. Aitkens S, Lord J, Bernauer E, Fowler WM Jr, Lieberman JS, Berck P. Relationship of manual muscle testing to objective strength measurements. Muscle Nerve 1989;12:173–177.
13. Matuja WB, Aris EA, Gabone J, Mgaya EM. Incidence and characteristics of Myasthenia gravis in Dar Es Salaam, Tanzania. East Afr Med J 2001;78:473–476.
14. Joensen P. Myasthenia gravis incidence in a general North Atlantic isolated population. Acta Neurol Scand 2014;130:222–228.
15. Hansen JS, Danielsen DH, Somnier FE, Frøslev T, Jakobsen J, Johnsen SP, et al. Mortality in myasthenia gravis: a nationwide population-based follow-up study in Denmark. Muscle Nerve 2016;53:73–77.
16. Markvardsen LH, Debost JC, Harbo T, Sindrup SH, Andersen H, Christiansen I, et al. Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2013;20:836–842.
17. Broekmans T, Gijbels D, Eijnde BO, Alders G, Lamers I, Roelants M, et al. The relationship between upper leg muscle strength and walking capacity in persons with multiple sclerosis. Mult Scler 2013;19:112–119.
18. Schnackenburg KE, Macdonald HM, Ferber R, Wiley JP, Boyd SK. Bone quality and muscle strength in female athletes with lover limb stress fractures. Med Sci Sports Exerc 2011;43:2110–2119.
19. Bastiani D, Ritzel CH, Bortoluzzi SM, Vaz MA. Work and power of the knee flexor and extensor muscles in patients with osteoarthritis and after total knee arthroplasty. Rev Bras Reumatol 2012;52:195–202.
20. Harbo T, Brincks J, Andersen H. Maximal isokinetic and isometric muscle strength of major muscle groups related to age, body mass, height, and sex in 178 healthy subjects. Eur J Appl Physiol 2012;112:267–275.
21. Andersen LG, Groenvold M, Joergensen T, Aadahl M. Construct validity of a revised Physical Activity Scale and testing by cognitive interviewing. Scand J Public Health 2010;38:707–714.
22. Symonette CJ, Watson BV, Koopman WJ, Nicolle MW, Doherty TJ. Muscle strength and fatigue in patients with generalized myasthenia gravis. Muscle Nerve 2010;41:362–369.
23. Cejvanovic S, Vissing J. Muscle strength in myasthenia gravis. Acta Neurol Scand 2014;129:367–373.
24. Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009;8:475–490.
25. Allman BL, Rice CL. Neuromuscular fatigue and aging: central and peripheral factors. Muscle Nerve 2002;25:785–796.
26. Martin HJ, Yule V, Syddall HE, Dennison EM, Cooper C, Aihie Sayer A. Is hand-held dynamometry useful for the measurement of quadriceps strength in older people? A comparison with the gold standard Biodex dynamometry. Gerontology 2006;52:154–159.
27. McGrogan A, Sneddon S, de Vries CS. The incidence of myasthenia gravis: a systematic literature review. Neuroepidemiology 2010;34:171–183.
28. Pedersen EG, Hallas J, Hansen K, Jensen PE, Gaist D. Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996–2009. Eur J Neurol 2013;20:309–314.